Xaira Therapeutics

The core technological advantage of AIXOR Exchange is embodied in its brand-new AI trading system-Genesis AI Pro 5.0. As an industry-leading AI-driven trading technology, Genesis AI Pro 5.0 features three core breakthroughs: - Adaptive to Market Changes, Smartly Optimizing Trading Strategies

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas.

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company") has been honored with the "Most Valuable Investment Award" at the 10th China Medical Industry Innovation Competition,

Another company involved in using AI to repurpose failed drugs - as well as drugs that have already been approved - is BioXcel Therapeutics. Unlike Ignota, however, the company focuses on compounds that have already demonstrated safety in prior clinical trials, but have been discontinued by their developers for various other reasons.

India], March 6: iSON Xperiences, a global leader in AI-driven customer experience (CX) solutions with a presence in 22 countries, has announced a strategic partnership with Aistra, an AI Adoption company,

London startup Quantexa has made its name over the years with an enterprise platform that employs AI and data analytics to fight money laundering and

Quinnox, an AI-first, digital-native technology leader, is driving AI-powered transformation through QAI Studio, a dedicated AI innovation lab designed to help enterprises fast-track AI adoption and achieve measurable business outcomes.

Iktos, a global leader in AI-driven drug discovery, has secured a prestigious €2.5 million grant from the European Innovation Council (EIC) Accelerator to advance its AI and robotics synthesis automation technology.